Isis Pharma (ISIS) Tops Q4 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Isis Pharma (ISIS) Remains Overbought Following Recent Run
March 2, 2015 3:14 PM ESTIsis Pharma (Nasdaq: ISIS) is largely in overbought territory as the stock's recent run is coming to a halt.
Market data has the 14-day money flow index at 81.4 percent, above the 80 percent overbought threshold. Overall, money flow is negative $3.1 million in afternoon trading for an... More
Stifel Downgrades ISIS Pharmaceuticals (ISIS) to Hold
March 2, 2015 6:35 AM ESTStifel downgraded ISIS Pharmaceuticals (NASDAQ: ISIS) from Buy to Hold and removed its price target (prior $66.00).
For an analyst ratings summary and ratings history on ISIS Pharmaceuticals click here. For more ratings news on ISIS Pharmaceuticals click here.
Shares of ISIS Pharmaceuticals closed at $68.56 yesterday.
... More